OWLT · XBRL financial data
Owlet financial statements, every fiscal year
The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (OWLT's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | †Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 75,403 | 75,842 | 69,202 | 54,010 | 78,056 | 105,708 |
| Cost of goods and services sold | 39,526 | 40,784 | 45,889 | 31,423 | 38,748 | 52,175 |
| Gross profit | 35,877 | 35,058 | 23,313 | 22,587 | 39,308 | 53,533 |
| Research and development | 10,465 | 21,427 | 27,896 | 10,349 | 9,801 | 14,076 |
| General and administrative | 13,140 | 32,339 | 41,547 | 27,343 | 33,967 | 29,245 |
| Total operating expenses | 42,868 | 90,850 | 107,932 | 51,219 | 59,528 | 61,794 |
| Operating income (loss) | (6,991) | (55,792) | (84,619) | (28,632) | (20,220) | (8,261) |
| Interest expense | 1,382 | 1,772 | 1,104 | 3,191 | 1,630 | 809 |
| Other income (expense) | (3,510) | (15,881) | 5,312 | (4,259) | 7,738 | (31,389) |
| Income tax expense (benefit) | 0 | 31 | 29 | 10 | 54 | 28 |
| Net income (loss) | (10,521) | (71,704) | (79,336) | (32,901) | (12,536) | (39,678) |
| Earnings per share, basic‡ USD per share | (6.76) | (15.92) | (10.00) | (4.53) | (1.57) | (2.31) |
| Earnings per share, diluted‡ USD per share | (6.76) | (15.92) | (10.00) | (4.53) | (1.57) | (2.27) |
| Weighted average shares, basic‡ thousands of shares | 1,559 | 4,488 | 7,903 | 8,276 | 10,951 | 18,094 |
| Weighted average shares, diluted‡ thousands of shares | 1,559 | 4,488 | 7,903 | 8,276 | 10,951 | 18,094 |
- ‡ Per-share figures and share counts are adjusted for the 1-for-14.084507042253522 stock split (July 2023); filings made before it reported them unadjusted.
- † Share count changed about 5x in the period ending 2021-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Balance sheet
CSVFiscal years (OWLT's year ends in late December)
- ‡ Per-share figures and share counts are adjusted for the 1-for-14.084507042253522 stock split (July 2023); filings made before it reported them unadjusted.
- † Share count changed about 5x in the period ending 2021-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Cash flows
CSVFiscal years (OWLT's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | †Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | (10,521) | (71,704) | (79,336) | (32,901) | (12,536) | (39,678) |
| Stock-based compensation | 1,070 | 4,259 | 12,856 | 9,933 | 8,633 | 9,348 |
| Depreciation and amortization | 873 | 1,133 | 1,418 | 842 | 452 | 521 |
| Net cash from operating activities | (129) | (40,556) | (81,380) | (23,527) | (11,209) | (10,792) |
| Purchases of property and equipment | 967 | 969 | 636 | 16 | 35 | 273 |
| Net cash from investing activities | (1,056) | (2,020) | (1,565) | (59) | (761) | (943) |
| Proceeds from issuing common stock | — | — | — | 0 | 10,003 | 32,109 |
| Proceeds from long-term debt | 3,000 | 5,000 | 0 | 500 | — | — |
| Repayments of long-term debt | 0 | 1,000 | 6,000 | 3,500 | 5,000 | 488 |
| Net cash from financing activities | 6,458 | 120,621 | (878) | 28,912 | 16,044 | 32,115 |
| Net change in cash | 5,273 | 78,045 | (83,823) | 5,326 | 4,074 | 20,380 |
- † Share count changed about 5x in the period ending 2021-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Compare with peers
SIC 3829 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3829 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Owlet | 30,948 | 33,865 | (92)* | 29.2M | 336.4 quarters | 10-QJun 30, 2026 |
| Alamar Biosciences | 121,532 | 33,545 | not reported | 69.5M | — | 10-QSep 30, 2026 |
| Hurco Companies | 52,087 | 47,289 | 3,805 | 6.5M | — | 10-QJul 31, 2026 |
| Geospace Technologies | 2,833 | 15,804 | (10,688)* | 12.9M | 0.3 quarters | 10-QJun 30, 2026 |
| Rapid Micro Biosystems | 14,687 | 8,054 | (12,702)* | not reported | 1.6 quarters | 10-QJun 30, 2026 |
| Intest | 22,102 | 35,313 | not reported | 12.8M | — | 10-QJun 30, 2026 |
| Seer | 26,075 | 3,102 | (9,571)* | 55.4M | 16.0 quarters | 10-QJun 30, 2026 |
| Kewaunee Scientific | 8,246 | 66,320 | 1,976 | 2.9M | — | 10-QJul 31, 2026 |
| Crawford United | 1,923 | not reported | 5,706* | not reported | — | 10-QSep 30, 2025 |
Not investment advice. Not affiliated with the U.S. SEC.